The FET-Open project MAGNEURON aims to develop a novel technology for magnetic actuation of cellular functions to treat Parkinson’s disease. The innovative concept of their technology is to remote-control the behaviour of cells using bio-functionalized magnetic nanoparticles.
MAGNEURON is led by Dr. Mathieu Coppey, from Institut Curie, France. The project includes 6 partners from France, Germany and the United Kingdom, covering the areas of Physical-Chemistry, Bio-chemistry, Biophysics, Nanosciences, Neurosciences and Regenerative medicine.
In his blog Dr. Mathieu Coppey discusses the project's rationale in trying to address Parkinson's disease.